Microsoft, Oxford Biomedica to apply cloud, machine learning to improving gene therapy
Source: https://ift.tt/2O3Ejhk
The partnership between the US software giant and UK-based biotech company is designed to increase the yield and improve the purity of lentiviral vectors in gene therapy.
Source: https://ift.tt/2O3Ejhk
0 Comments